Expert Interview
Discussing the standard of care and the potential of Janssen Pharma's TREMFYA along with the VISIBLE Phase 3b Study of TREMFYA® (Guselkumab) in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis
Ticker(s): JNJInstitution: Christiana Care Health System
- Rheumatologist, board-certified in internal medicine with special interest in scleroderma, lupus, myositis and ANCA-associated vasculitis.
- Presented at national meetings of the American College of Physicians, Society of Hospital Medicine and at the Pennsylvania Rheumatism Society.
- Contributions to medical literature include publications in CHEST, the Journal of Cardiac Failure and Journal of Pakistan Medical Association.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
